Sunday, November 15, 2026

Genetic prevalence of repeat expansion and other rare neurological disorders in the Quebec population

De Mori A, Labrecque M, Triassi V, Audet S, Pelletier J, Lai A, La Piana R, Duquette A, Bhérer C and Tetreault M (2026) Genetic prevalence of repeat expansion and other rare neurological disorders in the Quebec population. Front. Genet. 17:1964104. doi: 10.3389/fgene.2026.1964104 

Among the diseases expected to be enriched in the CaG cohort given their established association with the French-Canadian founder effect, FXN and DMPK variants were identified at elevated frequencies, as anticipated. The high CF of FXN variants is consistent with the autosomal recessive nature of FRDA, in which carriers are unaffected and therefore not excluded during recruitment of CaG participants. The recent approval of omaveloxolone as a therapy for FRDA further increases the clinical value of identifying expansion carriers early in the Quebec population


Scatter plot comparing the prevalence per one hundred thousand people of seven diseases (SCA27B, ALS/FTD, DM1, SCA2, FRDA, SBMA Male, SBMA Female) across three data sources: CaG (blue squares), Global (orange squares), and Quebec (green squares). DM1 in Quebec shows the highest prevalence at one hundred fifty-seven point nine eight, while SBMA Female in CaG is lowest at zero point zero two. Prevalence varies notably by disease and data source.